Cardiff Oncology
CRDF
CRDF
67 hedge funds and large institutions have $19.6M invested in Cardiff Oncology in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less capital invested
Capital invested by funds: $41M → $19.6M (-$21.3M)
69% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 32
Holders
67
Holding in Top 10
–
Calls
$445K
Puts
$385K
Top Buyers
| 1 | +$1.59M | |
| 2 | +$520K | |
| 3 | +$479K | |
| 4 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$474K |
| 5 |
E
Ergoteles
New York
|
+$405K |
Top Sellers
| 1 | -$4.32M | |
| 2 | -$4.01M | |
| 3 | -$3.64M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.04M |